Neuroprotective Sirtuin ratio reversed by ApoE4
Veena Theendakara(Buck Institute for Research on Aging), Dale E. Bredesen(University of California, Los Angeles), Varghese John(University of California, Los Angeles), Matthew J. Hart(The University of Texas at San Antonio Health Science Center), Rammohan V. Rao(Buck Institute for Research on Aging), Alexander Patent(Buck Institute for Research on Aging), Brittany Philpot(Buck Institute for Research on Aging), Karen S. Poksay(Buck Institute for Research on Aging), Qiang Zhang(Buck Institute for Research on Aging), Olivier Descamps(Hôpital de Jolimont), Sonia C. Flores(Buck Institute for Research on Aging), Clare A. Peters Libeu(Buck Institute for Research on Aging), Gabriellee Cailing(Buck Institute for Research on Aging)
Cited by 100
Related Papers
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
|European Heart Journal|2011|1.2k
Coupling endoplasmic reticulum stress to the cell death program
|Cell Death and Differentiation|2004|1.2k